Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer

MLA

Jin Zhang, et al. “Multi-Institutional Analysis Shows That Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.” European Urology, vol. 71, no. 2, Feb. 2017, pp. 257–66. EBSCOhost, https://doi.org/10.1016/j.eururo.2016.07.012.

APA

Jin Zhang, Sandra D. McFadden, Jeffrey M. Arbeit, Mohammed Alshalalfa, Nicole M. White, Emily B. Rozycki, Robert B. Den, Elai Davicioni, Nicholas Erho, Ha X. Dang, Robert Jeffrey Karnes, Abdallah M. Eteleeb, Christopher G. Maher, Shuang G. Zhao, & Ismael A. Vergara. (2017). Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer. European Urology, 71(2), 257–266. https://doi.org/10.1016/j.eururo.2016.07.012

Chicago

Jin Zhang, Sandra D. McFadden, Jeffrey M. Arbeit, Mohammed Alshalalfa, Nicole M. White, Emily B. Rozycki, Robert B. Den, et al. 2017. “Multi-Institutional Analysis Shows That Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.” European Urology 71 (2): 257–66. doi:10.1016/j.eururo.2016.07.012.